SCHEMBL4985950

SCHEMBL4985950

CCCC(CC)CC(CC)C(N)CC(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 4/20 0.37
SLC1A1 P43005 4/20 0.37
SLC1A3 P43003 3/20 0.37
GRIK1 P39086 3/20 0.37
GRIK2 Q13002 3/20 0.37
ALDH1A1 P00352 1/20 0.35
CACNA2D1 P54289 2/20 0.34
ADRA1A P35348 2/20 0.34
CACNB3 P54284 1/20 0.34
CACNA1C Q13936 1/20 0.34
PGR P06401 1/20 0.34
HTR2B P41595 1/20 0.34
CACNA2D2 Q9NY47 1/20 0.34
GPR84 Q9NQS5 4/20 0.33
BHMT Q93088 1/20 0.33
CHRM1 P11229 1/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4991054 0.89 CACNA2D1 (0.38) SLC1A2SLC1A1SLC1A3CACNA2D1ADRA1A
SCHEMBL4992819 0.83 ALDH1A1 (0.39) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL4990003 0.83 BHMT (0.39) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL325889 0.80 ALDH1A1 (0.42) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL325890 0.80 ALDH1A1 (0.42) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL5374127 0.79 SLC22A6 (0.38) SLC1A2SLC1A1SLC1A3CACNA2D1ADRA1A
SCHEMBL4994657 0.77 SLC1A2 (0.40) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL4987985 0.77 BHMT (0.39) SLC1A2SLC1A1SLC1A3CACNA2D1ADRA1A
SCHEMBL4986477 0.75 METAP1 (0.37) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL4986054 0.75 CACNA2D1 (0.36) SLC1A2SLC1A1SLC1A3ALDH1A1CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1886363-A Amino acids with affinity for the alpha2delta-protein WARNER LAMBERT CO (US) 2006-12-27 CN claimed
US-20050124668-A1 Amino acids with affinity for the alpha2delta-protein WARNER-LAMBERT COMPANY LLC 2005-06-09 US claimed
US-7388023-B2 Amino acids with affinity for the α2δ-protein WARNER-LAMBERT COMPANY LLC (US) 2008-06-17 US disclosed
US-20070129550-A1 AMINO ACIDS WITH AFFINITY FOR THE ALPHA-2-DELTA-PROTEIN WANER-LAMBERT COMPANY LLC (US) 2007-06-07 US disclosed
US-7179934-B2 Amino acids with affinity for the α2δ-protein WARNER-LAMBERT COMPANY LLC (US) 2007-02-20 US disclosed
CN-1886363-A Amino acids with affinity for the alpha2delta-protein WARNER LAMBERT CO (US) 2006-12-27 CN disclosed
EP-1667957-A2 AMINO ACIDS WITH AFFINITY FOR THE ALPHA2DELTA-PROTEIN Warner-Lambert Company LLC (US) 2006-06-14 EP disclosed
US-20050124668-A1 Amino acids with affinity for the alpha2delta-protein WARNER-LAMBERT COMPANY LLC 2005-06-09 US disclosed
US-20050101643-A1 Amino acids with affinity for the alpha2delta-protein WARNER-LAMBERT COMPANY LLC 2005-05-12 US disclosed
WO-2005030700-A2 AMINO ACIDS WITH AFFINITY FOR THE ALPHA2DELTA-PROTEIN WARNER-LAMBERT COMPANY LLC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124668-A1 Amino acids with affinity for the alpha2delta-protein SCN2A, SCN1A, OPRD1 SLC1A2 57/4885SLC1A1 106/4885SLC1A3 118/4885
US-20070129550-A1 AMINO ACIDS WITH AFFINITY FOR THE ALPHA-2-DELTA-PROTEIN SCN2A, OPRD1, SCN1A SLC1A2 42/4885SLC1A1 111/4885SLC1A3 128/4885
US-20050101643-A1 Amino acids with affinity for the alpha2delta-protein SCN2A, OPRD1, SCN1A SLC1A2 29/4885SLC1A1 91/4885SLC1A3 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.